P2U(P2Y2)-PURINOCEPTOR AND WATER TRANSPORT IN RAT KIDNEY
P2U(P2Y2)-嘌呤受体和大鼠肾脏中的水转运
基本信息
- 批准号:6517989
- 负责人:
- 金额:$ 22.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-06-01 至 2005-05-31
- 项目状态:已结题
- 来源:
- 关键词:arginine vasopressin body water dehydration cellular polarity eicosanoid metabolism histology hormone regulation /control mechanism immunologic assay /test laboratory rat membrane permeability nutrition related tag osmotic pressure protein localization purinergic receptor receptor expression renal tubular transport thirst water
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Renal collecting duct
water permeability is regulated by a complex interplay among different
signaling pathways, which are linked to various membrane receptors. While
arginine vasopressin (AVP), acting through its V2 receptor and the camp second
messenger system, increases the water permeability of the collecting duct, a
variety of autocrine and paracrine agents (e.g. prostaglandins, endothelin),
acting through their respective membrane receptors and the phosphoinositide
signaling pathway, down regulate the water permeability of the collecting duct.
One such receptor is the P2Y2-purinoceptor (P2u-purinoceptor), which is
activated by extracellular nucleotides (ATP or UTP). The long term goal of this
application is to decipher the cellular and molecular mechanisms involved in
the down regulation of AVP-induced water permeability in the IMCD by the
activation of P2Y2-purinoceptor. The applicant has already (i) demonstrated
that agonist activation of P2Y2-purinoceptor down regulates the AVP-induced
osmotic water permeability (Pf) in microperfused rat inner medullary collecting
duct (IMCD), (ii) developed a gene specific cDNA probe and peptide-derived
polyclonal antibody to P2Y2-purinoceptor, and localized the receptor mRNA and
protein in the rat IMCD, (iii) obtained preliminary evidence that agonist
stimulation of P2Y2-purinoceptor in rat IMCD releases prostaglandin E2, and
(iv) observed that P2Y2-purinoceptor mRNA and protein in the inner medullae of
thirsted and hydrated rats are markedly altered, associated with an altered
subcellular distribution of the receptor protein in the IMCD. Based on these
observations of the applicant, the specific aims of the application are: (i) to
investigate the role and contribution of apical and basolateral purinoceptor
and the modulation of AVP-stimulated Pf of rat IMCD, (ii) to investigate the
roles of cycloxygenase and cytosolic phospholipase A2 in the release of
prostaglandins by the agonist stimulation of P2Y2-purinoceptor in rat IMCD,
(iii) to investigate the role and contribution of P2Y2-purinoceptor in simple
physiological rat models of thirsting and hydration. To achieve these, the
applicant proposes to use rat models of thirsting and hydration and to perform
(i) functional studies on in vitro microperfused IMCD, (ii) molecular studies
to determine mRNA and protein expression levels, (iii) subcellular localization
of the receptor protein by immunoperoxidase labeling on cryosections and
immunogold labeling on ultrathin sections, (iv) studies on IMCD suspensions to
detect the alterations in the arachidonic acid metabolism. Successful
completion of these studies will lead to significant insights into the
AVP-independent mechanisms of regulation of collecting duct water permeability.
描述(改编自申请人的摘要):肾脏收集管道
水的渗透性受不同的相互作用的调节
信号通路,与各种膜受体有关。尽管
精氨酸加压素(AVP),通过其V2受体作用,第二个营地第二
Messenger系统,增加了收集管的水渗透性,A
多种自分泌和旁分泌剂(例如前列腺素,内皮素),
通过各自的膜受体和磷酸肌醇作用
信号通路,向下调节收集管的水渗透性。
一个这样的受体是P2Y2-吡只受体(P2U-Purinoceptor),它是
被细胞外核苷酸(ATP或UTP)激活。这个长期目标
应用是破译参与的细胞和分子机制
AVP诱导的IMCD中AVP诱导的水的渗透性的下降调节
P2Y2-Purinoceptor的激活。申请人已经证明了
P2Y2-Purinoceptor的激动剂激活调节AVP诱导的
微孔大鼠内髓质收集中的渗透性水渗透率(PF)
导管(IMCD),(ii)开发了基因特异性cDNA探针和肽来源
抗P2Y2-纤维杆菌的多克隆抗体,并将受体mRNA和
大鼠IMCD中的蛋白质(iii)获得了激动剂的初步证据
大鼠IMCD中P2Y2-Purinoceptor的刺激释放前列腺素E2,并且
(iv)观察到p2y2- purinoceptor mRNA和蛋白
口渴和水合大鼠明显改变,与改变
IMCD中受体蛋白的亚细胞分布。基于这些
对申请人的观察,申请的具体目的是:(i)
研究顶端和基底外侧purinoceptor的作用和贡献
以及大鼠IMCD的AVP刺激的PF的调节(ii)研究
环加糖酶和胞质磷脂酶A2在释放中的作用
Prostaglandins通过大鼠IMCD中P2Y2-Purinoceptor的激动剂刺激,
(iii)调查P2Y2-Purinoceptor在简单中的作用和贡献
渴求的生理大鼠模型。为了实现这些目标,
申请人建议使用渴求的大鼠模型,并执行
(i)关于体外微灌注IMCD的功能研究,(ii)分子研究
确定mRNA和蛋白质表达水平,(iii)亚细胞定位
免疫过氧化物酶在冷冻切片和
超薄切片上的免疫元标记,(iv)IMCD悬浮液的研究
检测蛛网膜酸代谢的改变。成功的
这些研究的完成将导致对
非AVP独立于收集管道渗透性调节的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BELLAMKONDA K KISHORE其他文献
BELLAMKONDA K KISHORE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BELLAMKONDA K KISHORE', 18)}}的其他基金
Targeting Renal Purinergic Signaling for the Treatment of Lithium-induced NDI
靶向肾脏嘌呤信号传导治疗锂诱导的 NDI
- 批准号:
8195888 - 财政年份:2010
- 资助金额:
$ 22.31万 - 项目类别:
Targeting Renal Purinergic Signaling for the Treatment of Lithium-induced NDI
靶向肾脏嘌呤信号传导治疗锂诱导的 NDI
- 批准号:
8397534 - 财政年份:2010
- 资助金额:
$ 22.31万 - 项目类别:
Targeting Renal Purinergic Signaling for the Treatment of Lithium-induced NDI
靶向肾脏嘌呤信号传导治疗锂诱导的 NDI
- 批准号:
7931303 - 财政年份:2010
- 资助金额:
$ 22.31万 - 项目类别:
Targeting Renal Purinergic Signaling for the Treatment of Lithium-induced NDI
靶向肾脏嘌呤信号传导治疗锂诱导的 NDI
- 批准号:
8259070 - 财政年份:2010
- 资助金额:
$ 22.31万 - 项目类别:
Targeting Renal Purinergic Signaling for the Treatment of Lithium-induced NDI
靶向肾脏嘌呤信号传导治疗锂诱导的 NDI
- 批准号:
9907855 - 财政年份:2009
- 资助金额:
$ 22.31万 - 项目类别:
Potential Therapeutic Applications of Ecto-Nucleotidases in Lithium-induced NDI
外切核苷酸酶在锂诱导 NDI 中的潜在治疗应用
- 批准号:
7878061 - 财政年份:2009
- 资助金额:
$ 22.31万 - 项目类别:
Targeting Renal Purinergic Signaling for the Treatment of Lithium-induced NDI
靶向肾脏嘌呤信号传导治疗锂诱导的 NDI
- 批准号:
9339491 - 财政年份:2009
- 资助金额:
$ 22.31万 - 项目类别:
Targeting Renal Purinergic Signaling for the Treatment of Lithium-induced NDI
靶向肾脏嘌呤信号传导治疗锂诱导的 NDI
- 批准号:
8921910 - 财政年份:2009
- 资助金额:
$ 22.31万 - 项目类别:
Potential Therapeutic Applications of Ecto-Nucleotidases in Lithium-induced NDI
外切核苷酸酶在锂诱导 NDI 中的潜在治疗应用
- 批准号:
7660114 - 财政年份:2009
- 资助金额:
$ 22.31万 - 项目类别:
Targeting Renal Purinergic Signaling for the Treatment of Lithium-induced NDI
靶向肾脏嘌呤信号传导治疗锂诱导的 NDI
- 批准号:
9040769 - 财政年份:2009
- 资助金额:
$ 22.31万 - 项目类别:
相似海外基金
Water Intake and Weight Control in Older Adults
老年人的饮水量和体重控制
- 批准号:
10582833 - 财政年份:2023
- 资助金额:
$ 22.31万 - 项目类别:
Drosophila as a model to study modifiers of Cystic Fibrosis
果蝇作为研究囊性纤维化修饰因子的模型
- 批准号:
10593250 - 财政年份:2022
- 资助金额:
$ 22.31万 - 项目类别:
Parsing the central control of thirst and hunger using a rat model of diabetes insipidus
使用尿崩症大鼠模型解析口渴和饥饿的中枢控制
- 批准号:
10684254 - 财政年份:2022
- 资助金额:
$ 22.31万 - 项目类别:
Novel Strategies to Clear Bacteria from the CF Lung
清除 CF 肺细菌的新策略
- 批准号:
10680454 - 财政年份:2022
- 资助金额:
$ 22.31万 - 项目类别:
NMR-Based Rapid Fluid Assessment: Device Design and Signal Processing
基于 NMR 的快速流体评估:设备设计和信号处理
- 批准号:
10441674 - 财政年份:2022
- 资助金额:
$ 22.31万 - 项目类别: